









Markets
/
Stocks
/
nasdaq-nbp
/

Novabridge Biosciences ADR

NBP

3.960USD

-0.130-3.18%

Market hours （ET）Quotes delayed by 15 min

323.87MMarket Cap

LossP/E TTM



Novabridge Biosciences ADR

3.960

-0.130-3.18%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Novabridge Biosciences ADR here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Total equity

Cash, cash equivalents and short-term investments

--165.61M

- Cash and cash equivalents

--165.40M

-Short-term investments

--210.00K

Prepaid expenses

--2.03M

Total current assets

--167.64M

Non-current assets

Net Fixed Assets

--3.38M

Other non-current assets

--1.22M

Total non-current assets

--39.07M

Total assets

--206.71M

Liabilities

Current liabilities

Total current liabilities

--7.35M

Non-current liabilities

Long-term debt and lease liabilities

--2.63M

-Long-term lease liabilities

--2.63M

Total non-current liabilities

--2.63M

Total liabilities

--9.97M

Shareholders' equity

Common equity

--1.46B

Retained earnings

---1.29B

Capital reserves

--1.46B

Less: Treasury stock

--5.61M

Gains losses not affecting retained earnings

--37.04M

Total equity

--196.73M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

